Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Grant Challen
preleukemia, leukemia
Jing Fu
myeloma
Peter Croucher
Multiple Myeloma
Carma Bylund
Equity in Access
Andrew Lane
BPDCN
Michaela Reagan
Multiple Myeloma
Wendy Béguelin
follicular lymphoma
Julia Maxson
AML
Jing Yang
Myeloma
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Catherine Diefenbach
DLBCL immunology
Eirini Papapetrou
blood cancer stem cells
Manyi Wei
acute megakaryoblastic leukemia
Anouchka Laurent
T-cell lymphoma
Keisuke Ito
blood cancer stem cells and MDS metabolism
Coleman Lindsley
AML/MDS
Ari Melnick
epigenetics and lymphoma
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Jeffrey Magee
pediatric AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Kimberly Stegmaier
childhood blood cancers
Lindsey Montefiori
pediatric leukemia
Jennifer Woyach
CLL trials
Reina Takeda
AML
Steven Park
follicular lymphoma
Ravindra Majeti
preleukemia, AML
H. Irene Su
Equity in Access
Tomasz Skorski
myeloproliferative neoplasms, AML
Rachel Mersfelder
AMKL
Nicolas Nassar
pediatric leukemia
Mark Hamilton
DLBCL and CAR-T
Pietro Genovese
transplant and AML
Jennifer Amengual
lymphomas after transplant
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Christopher Porter
Leukemia, lymphoma
Yiman Liu
Epigenetics and leukemia
Matteo Bellone
Smoldering multiple myeloma
ImCheck Therapeutics
immunotherapy, AML
Jeetayu Biswas
splicing in myeloid diseases
Adam de Smith
pediatric ALL and Down Syndrome
Koichi Takahashi
AML/MDS
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Stephen Gottschalk
pediatric leukemia and CAR-T
Soheil Meshinchi
pediatric AML
Jonas Jutzi
myeloproliferative neoplasms
Maximilian Stahl
AML immunotherapy
Qing Yi
Novel CAR-T
Solu Therapeutics
immunotherapy, CMML
Jianguo Tao
Mantle Cell Lymphoma
Eric Pietras
AML
Michael Wang
Mantle Cell Lymphoma
Ricky Johnstone
lymphoma and myeloma
Thomas LeBlanc
palliative care
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Wendy Stock
T-cell ALL
Timothy Graubert
AML and MDS biology
Mala Shanmugam
myeloma
Suman Paul
T cell cancers and immunotherapy
Nataly Cruz-Rodriguez
T-ALL and metabolism
Matthew Frank
Lymphoma CART therapy
Marc Seifert
Hairy cell leukemia
Daniel Herranz
T-ALL
Jalpa Doshi
Equity in Access
Trent Hall
MDS
Jaehyuk Choi
T-cell lymphoma
Nicoletta Cieri
AML and transplantation
Omar Abdel-Wahab
Hairy cell leukemia
Eric Padron
CMML
Steven Treon
Lymphomas and Waldenstrom's
Christopher Booth
BPDCN
Justine Kahn
pediatric leukemia and lymphoma
Paul Beavis
immunotherapy in myeloma
Jayna Mistry
aging and leukemias
Thomas Kipps
Hairy Cell Leukemia
Rajni Kumari
AML
Rong Lu
preleukemia, leukemia
Jonathon Cohen
lymphoma clinical trial access in Georgia
Megan McNerney
AML/MDS
Meng Li
Equity in Access
Sham Mailankody
Myeloma immunotherapy clinical trials
Stephen Nimer
myeloid cancer biology
Brian Walker
smoldering myeloma, MGUS
Jolanta Grembecka
leukemia therapeutics
Srividya Swaminathan
pediatric, immunotherapy
Fahmin Basher
transplant and GvHD
Lawrence Boise
CART and myeloma
Bingyi Chen
AML immunotherapy
Lori Muffly
Equity in Access
Venkata Lokesh Battula
immunotherapy and AML
Elliot Stieglitz
CMML
Taishi Yonezawa
AML
Courtney DiNardo
clinical trials, AML
Bruno Paiva
smoldering myeloma
Huda Salman
CMML
Jianhua Yu
myeloma immunotherapy
Martin Dreyling
Mantle Cell Lymphoma
Ana Vujovic
AML
Stacie Dusetzina
Equity in Access
Adi Nagler
Bronchiolitis obliterans after transplant
Kasey Leger
pediatric blood cancers
Yan Liu
MDS
Nirav Shah
CAR-T for lymphoma
Faron Pharmaceuticals
immunotherapy, MDS
Robert Soiffer
transplantation
Roberta Zappasodi
lymphoma, immunotherapy
Steven Horwitz
T-cell lymphomas
Mendel Goldfinger
MDS/AML trials for the elderly
Robert Orlowski
(Smoldering) Multiple Myeloma
Sheng Li
Aging and AML
Liran Shlush
pre-leukemia
John DiPersio
trispecific antibody for AML and MDS
Eugenio Morelli
Myeloma
Suzanne Lentzsch
Myeloma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Catherine Smith
leukemia
Rgenta Therapeutics
RNA-targeting, blood cancer
Simona Colla
Myeloma biology
Tanya Siddiqi
clinical trial access
Kerry Rogers
CLL
Armin Rashidi
gut bacteria and transplant success
Carl Allen
pediatric blood cancers
Raymond Mailhot
Equity in Access
Pooja Khandelwal
bone marrow transplantation
Peter Klein
MDS
Alexey Danilov
lymphoma
Kura Oncology
MLL leukemia, AML
Madhav Dhodapkar
multiple myeloma immunotherapy
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Oreofe Odejide
Equity in Access
George Vassiliou
Leukemia Prevention
Ravi Bhatia
transplantation
Grzegorz Nowakowski
Clinical trial access
Jonathan Licht
DNA biology, myeloma
Roland Walter
Antibody-based AML therapies
Saar Gill
AML immunotherapy
Jean Koff
Disparities in DLBCL
Bing Carter
p53 mutant AML
Dimericon Therapeutics
dimericons, blood cancer
Daisuke Nakada
preleukemia, leukemia
Ann-Kathrin Eisfeld
Racial diversity in AML
John Leonard
lymphoma research
Sriram Sundaravel
AML stem cells
Christine Zhang
AML
Yoke Seng Lee
AML
Lev Kats
myeloma and epigenetics
Paolo Caimi
CAR-T clinical trial for CLL
Jeremy Baeten
AML
Enterome
vaccine, FL, MZL
Caner Saygin
T-ALL
Qingyu Luo
BPDCN
Hong Wen
AML
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Yibin Yang
Lymphoma
Shazia Nakhoda
Equity in Access
Daniel Pollyea
AML
Riccardo Dalla-Favera
lymphoma (DLBCL)
Hao Jiang
DNA biology and leukemia
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Courtney Jones
AML metabolism
Xu Ji
Equity in Access
Tycel Phillips
Mantle Cell Lymphoma
Gianpietro Dotti
CAR T and AML
Ruben Carrasco
Myeloma
Christian Marinaccio
MLL leukemias
Carl June
CAR T immunotherapy
Anushree Vichare
Equity in Access
Ronald Levy
immunotherapies, COVID-19
Dane Vassiliadis
blood cancer biology
Amit Verma
AML/MDS
Alieen Rowan
Adult T cell leukemia/lymphoma
Caron Jacobson
lymphoma and immunotherapy
Shannon Maude
Immunotherapy for ALL
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Michael Kharas
leukemia
Luca Busino
DLBCL
Nicola Vannini
Aging and CAR-T success
Mark Dawson
B-ALL and CAR-T resistance
Tak Mak
Immunotherapy
George Daley
"off-the-shelf" CAR-T and CAR-NK
Siegfried Janz
Myeloma immunotherapy
Ramon Massoni-Badosa
CLL and Richter's Syndrome
William Matsui
Myeloma
Daniel Thomas
Myelofibrosis
Teresa Palomero
Peripheral T-cell Lymphoma
Catherine Bollard
pediatric blood cancers and immunotherapy
Alex Kentsis
pediatric leukemias
Cailin Collins
Leukemia and pre-leukemia
John Crispino
myelofibrosis, pediatric leukemia and Downs
Jessica Stewart
Epstein-barr virus and lymphomas
Yubin Zhou
peripheral T cell lymphoma
Jenny Wang
AML
Jake Shortt
precision therapy for aggressive lymphomas
Christopher Flowers
clinical trial access
Urvi Shah
Diet and myeloma
Thomas Koehnke
leukemia
Noemí Puig Morón
Myeloma
Julia Paczkowska
immunobiology of Hodgkin's disease
Tyler Parsons
MPN and AML
Siddhartha Jaiswal
preleukemia
BioInvent International
immunotherapy, indolent NHL, CTCL
Leandro Cerchietti
DLBCL
Michael Green
lymphoma biology
Sahand Hormoz
MPN
Jun Qi
Myeloma
Nizar Bahlis
Myeloma immunotherapy
Sarah Tasian
pediatric leukemias
Joachim Yahalom
Lymphoma
Sam Butterworth
CMML
Liling Wan
AML
Sergei Doulatov
Leukemias
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Nitin Jain
CLL
Philippe Armand
follicular lymphoma
Catriona Jamieson
cancer stem cell biology
Craig Jordan
AML
Alfred Garfall
myeloma immunotherapy
Helen Parsons
Equity in Access
Richard Lock
T-ALL
Kirk Schultz
pediatric transplantation
Christian Steidl
B-cell lymphomas
Marina Konopleva
MDS/AML metabolism
Randall Davis
CLL
Piers Patten
COVID-19
F. Lennie Wong
Equity in Access
Jennifer Trowbridge
aging and leukemia
Logan Spector
childhood leukemia epidimiology
Michael Keller
COVID-19, immunotherapy
Kathleen Sakamoto
pediatric AML
Daniel Lucas
bone marrow and leukemia biology
Rizwan Romee
Immunotherapy
Inhye Ahn
CLL
Brian Dalton
DNA mutations and myeloid cancers
Takeshi Sugio
T-cell lymphoma
Mark Murakami
follicular lymphoma
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
James Rubenstein
Lymphoma of the Central Nervous System
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Affimed
immunotherapy, HL, PTCL
Enrico Tiacci
Hairy cell leukemia
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Neha Mehta-Shah
T-cell lymphoma
Bailee Kain
AML and African ancestry
Sigurður Kristinsson
Smoldering myeloma
Paolo Strati
Non-Hodgkin Lymphoma
Dan Landau
cancer evolution biology
Frederick Locke
lymphoma and immunotherapy
Fenghuang Zhan
Myeloma and bone disease
Adam Olszewski
Follicular and marginal zone lymphoma
Markus Muschen
leukemia and lymphoma biology
Margaret Shipp
lymphoma biology
Anthony Letai
improving CAR-T
Lucy Godley
preleukemia
Caroline Arber
myeloma CAR-T
Marco Ruella
Immunotherapy for T-cell lymphoma
Constellation Pharmaceuticals
myeloproliferative neoplasms
Gaurav Goyal
Erdheim-Chester Disease
Britta Will
Leukemia and pre-leukemia
Michael Savona
MDS and leukemia